Alps Medical Breakthroughs ETF (SBIO)
$40.08 1.04 (2.53%)
19:59 EST SBIO Stock Quote Delayed 15 Minutes
Previous Close $40.08
Market Cap 182.36M
PE Ratio -
Volume (Avg. Vol.) 69,100
Day's Range 39.72 - 41.37
52-Week Range 30.14 - 43.96
Dividend & Yield 0.58 (1.44%)
SBIO Stock Predictions, Articles, and Alps Medical Breakthroughs ETF News
- From InvestorPlace
- From the Web
The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.
If you're looking to invest in a particular corner of the market, odds are good there's a thematic ETF for you. Here are 5 to take a look at.
As the Best ETFs contest enters its final quarter, there are a few contenders that could reasonably take the trophy for 2018.
On a year-to-date basis, SBIO still looks good, up 14.30%, or 310 basis points better than the Nasdaq Biotechnology Index. Year-to-date, SBIO is also outpacing the equal-weight S&P Biotechnology Select Industry Index.
The bull market has been going on for a long time, but if you want to focus on securities with some growth left, these are great ETFs to buy.
As our Best ETFs for 2018 contest crosses into the second half of the year, a few contestants are really making standout gains, but others are making strong moves.
We have presented five ETFs & stocks that have easily crushed the Russell 2000 index this year and are likely to continue their strong performance. Compare....
Data support the notion that biotechnology stocks offer outperformance potential over diversified healthcare benchmarks. And these 5 biotech ETFs are a great to play the space.
My pick for the Best ETFs contest, SBIO, is outpacing the Nasdaq Biotechnology Index by 600 basis points with the first quarter drawing to a close.
Which funds are going to kick the competition to the curb this year? We have 10 experts who think they know the best ETFs for 2018.
Trying to pick just the right biotech stock to invest in? The ALPS Medical Breakthroughs ETF (SBIO) eases that burden.
It doesn't matter who is in charge; biotech stocks will always be major growth engines. Here are three of the best biotech ETFs to buy.
Let's take a look Inside four heavily losing ETFs in the year-to-date frame.
Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain.